Table 2.
Distribution of comorbidities by sex, race, and ethnicity
| All | Female | Male | White | Black | Non-Hispanic | Hispanic | |
| Number of patients, n | 145 | 73 | 72 | 102 | 37 | 126 | 13 |
| Comorbidities, n (%) | |||||||
| Autoimmune | 41 (28.3%) | 24 (32.9%) | 17 (23.6%) | 28 (27.5%) | 11 (29.7%) | 38 (30.2%) | 1 (7.7%) |
| Excluding diabetes | 27 (18.6%) | 19 (26.0%) | 8 (11.1%) | 20 (19.6%) | 5 (13.5%) | 24 (19.0%) | 1 (7.7%) |
| Diabetes only | 7 (4.8%) | 3 (4.1%) | 4 (5.6%) | 3 (2.9%) | 4 (10.8%) | 7 (5.6%) | 0 (0.0%) |
| Diabetes type 2 only | 7 (4.8%) | 2 (2.7%) | 5 (6.9%) | 5 (4.9%) | 2 (5.4%) | 7 (5.65%) | 0 (0.0%) |
| Malignancy | 21 (14.5%) | 10 (13.7%) | 11 (15.3%) | 18 (17.6%) | 3 (8.1%) | 20 (15.9%) | 1 (7.7%) |
| Postpartum | 5 (3.4%) | 5 (6.8%) | NA | 5 (4.9%) | 0 (0.0%) | 4 (3.2%) | 1 (7.7%) |
| Surgery/procedure/PICC/IV | 17 (11.7%) | 8 (11.0%) | 9 (12.5%) | 14 (13.7%) | 3 (8.1%) | 16 (12.7%) | 1 (7.7%) |
| Trauma | 2 (1.4%) | 2 (2.7%) | 0 (0.0%) | 2 (2.0%) | 0 (0.0%) | 2 (1.6%) | 0 (0.0%) |
| Other | 23 (15.9%) | 12 (16.4%) | 11 (15.3%) | 15 (14.7%) | 8 (21.6%) | 21 (16.7%) | 2 (15.4%) |
| None specified | 64 (44.1%) | 28 (38.4%) | 36 (50.0%) | 42 (41.2%) | 18 (48.6%) | 53 (42.1%) | 7 (53.8%) |
IV, intravenous; NA, not applicable; PICC, peripherally inserted central catheters.